Judit P Banáth

Affiliations
  • Integrative Oncology Department, BC Cancer Research Centre, Room 10-108, 675 West 10th Avenue, Vancouver, British Columbia, V5Z 1L3, Canada.

Publications (4)

Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.

Breast cancer research : BCR
Avec: Momir Bosiljcic , Rachel A Cederberg , Melisa J Hamilton , Nancy E LePard , Bryant T Harbourne , Jenna L Collier , Elizabeth C Halvorsen , Rocky Shi , S Elizabeth Franks , Ada Y Kim , Mark Hamer , Fabio M Rossi , Kevin L Bennewith

DNA-PK inhibition extends the therapeutic effects of Top2 poisoning to non-proliferating cells, increasing activity at a cost.

Scientific reports
Avec: Taixiang Wang , Alastair H Kyle , Jennifer H E Baker , Nannan A Liu , Andrew I Minchinton

Radiation and chemo-sensitizing effects of DNA-PK inhibitors are proportional in tumors and normal tissues.

Molecular cancer therapeutics
Avec: Jennifer H E Baker , Alastair H Kyle , Nannan Anam Liu , Taixiang Wang , Xinhe Liu , Sevin Teymori , Andrew I Minchinton

DNA-PK inhibitor AZD7648 is a more portent radiosensitizer than PARP inhibitor Olaparib in BRCA1/2 deficient tumors.

DNA repair
Avec: Taixiang Wang , Alastair H Kyle , Jennifer H E Baker , Nannan A Liu , Sevin Teymori , Andrew I Minchinton

Réseau de co-auteurs

Taixiang Wang 3 collaborations
Alastair H Kyle 3 collaborations
Jennifer H E Baker 3 collaborations
Andrew I Minchinton 3 collaborations
Nannan A Liu 2 collaborations
Sevin Teymori 2 collaborations
Momir Bosiljcic 1 collaboration
Rachel A Cederberg 1 collaboration
Melisa J Hamilton 1 collaboration
Nancy E LePard 1 collaboration
Bryant T Harbourne 1 collaboration
Jenna L Collier 1 collaboration
Elizabeth C Halvorsen 1 collaboration
Rocky Shi 1 collaboration
S Elizabeth Franks 1 collaboration
Ada Y Kim 1 collaboration
Mark Hamer 1 collaboration
Fabio M Rossi 1 collaboration
Kevin L Bennewith 1 collaboration
Nannan Anam Liu 1 collaboration
Xinhe Liu 1 collaboration